Event: Westerhoff Speaking at Chemical Computing Group UGM 2010, Montreal, Quebec

Title: Theory to Application: How Quantum Mechanics is Being Applied to Structure-Based Drug Discovery Using MOE and DivCon

Abstract: Traditionally, linear scaling, quantum mechanics-based methods for characterization of target/ligand complexes have been better suited to academic environments as they are sometimes difficult applications to access in the industrial domain. Recently, QuantumBio has been working to bridge that gap through the development of several interaction profiling tools specifically tailored to the structure-based drug discovery world. When plugged into MOE, these tools – including scoring, pairwise interaction energy decomposition, QSAR, and so on – become even better integrated with the workflows commonly used in the field. To date, this work has lead to the development of three major MOE svl plugins: MOE/QMScore, MOE/NMRScore, and MOE/QM-PWD. We are now able to prepare any number of QM simulations using the MOE graphical user interface (GUI), execute the simulations in parallel using MOE’s message passing infrastructure, and finally import the results back into the MOE GUI for further analysis.

As a use case, these QM simulations have been carried out for a series of protein kinase B inhibitors derived from fragment (FBDD) and structure-based drug design (SBDD). These protein-ligand complexes were selected because they represent a consistent set of experimental data that includes both crystal structures and affinities. Seven scoring functions were constructed based on a mixture of several quantum- and molecular- mechanical methods. The optimal models obtained by statistical analysis of the aligned poses are predictive as measured by a number of standard statistical criteria and validation with an external data set. Together, this model provides residue-based contributions to the overall binding affinity, and these results can be treated using both native MOE analytical methodologies and customized widgets including the QM-PWD Interaction Energy (IE) Map, Structure/Activity Relationship (SAR) Map, results tables, and so on. The IE map highlights the most important residues for ligand binding, while the SAR Map highlights residues that are most critical to discriminating between more and less potent ligands. Taken together the Interaction Energy and SAR Maps provide useful insights into drug design that would be difficult to garner in any other way.

Speaker: Lance M. Westerhoff,

Conference: Chemical Computing Group User Group Meeting.